Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
CJC-1295 (No DAC) / Ipamorelin / GHRP-2 Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: CJC-1295 without Drug Affinity Complex (No DAC), Ipamorelin, and Growth HormoneReleasing Peptide-2 (GHRP-2)
In January 2025, the firm published results of a Phase 2 trial for VK2735 with strong potential, including up to nearly 15% of baseline body weight lost in trial participants without a clear plateau
Ideally need two sessions 10 days apart to see results This treatment is completely safe, and will show results from 24 hours.
We have also incorporated various tools and modules in PEPlife to assist users in searching, comparing and analyzing the peptides, their half-lives and the related details
Limitations of waiting 6 months before escalation The conventional approach of waiting 6 months before adjusting treatment strategies presents substantial drawbacks for GLP-1 non-responders
US$ 21.33
US$ 22.60
US$ 20.49
US$ 22.34
US$ 20.98
